BullFrog AI Signs Groundbreaking Partnership with Lieber Institute

BullFrog AI (Nasdaq: BFRG), a precision medicine company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, signed a groundbreaking five-year global strategic partnership with the Lieber Institute for Brain Development (LIBD), a Johns Hopkins University-affiliated non-profit research institute that maintains the world's largest repository of postmortem brains for the study of neuropsychiatric disorders. Learn more at BFRGinfo.com.